Need testing solution is prepared: get sennae medicinal powder (crossing No. Therefore, take suitable concocting method to reduce the content of anthraquinone glycoside composition in sennae so that it is the discharge function namely maintaining mitigation also can reduce side effect simultaneously, to guaranteeing that the safe and effective use of sennae is significant. Gi tract are had hormesis by anthracene quinone and derivative thereof, heavy dose or prolonged application anthraquinone derivative, there is intestinal mucosa and injury of nerve plexus effect, make enteron aisle synthetic product reduce or accelerate the exhaustion of enteron aisle neuropeptide, cause the side effects such as stomachache, massive bleeding from upper digestive tract, in addition anthracene quinone class is to the stimulation of pallium, of short duration brain function can be caused abnormal, dizziness can be caused, the side effects such as lip, face, numbness of the limbs, taking the lighter for a long time and cause hypokalemia, severe one causes liver cirrhosis. It is referred to as anthraglucosennin constituents by the dianthrone analog derivative of representative of Sennoside A, B, C, D, rhabarberone-dianthrone-two glucoside etc., it it is the significant part that in sennae, content is higher, also it is main active ingredient under sennae is rushed down, antibacterial, but also it is the main component causing sennae side effect simultaneously. G01N30/8624- Detection of slopes or peaks baseline correction.G01N30/04- Preparation or injection of sample to be analysed.chromatography or field flow fractionation G01N30/00- Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g.G01N- INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from CN201410707543 external-priority Application filed by Xi'an Jishangji Enterprise Marketing Consulting Co Ltd, Chengdu University of Traditional Chinese Medicine filed Critical Xi'an Jishangji Enterprise Marketing Consulting Co Ltd Publication of CN105651905A publication Critical patent/CN105651905A/en Status Pending legal-status Critical Current Links Original Assignee Xi'an Jishangji Enterprise Marketing Consulting Co Ltd Chengdu University of Traditional Chinese Medicine Priority date (The priority date is an assumption and is not a legal conclusion. Xi'an Jishangji Enterprise Marketing Consulting Co LtdĬhengdu University of Traditional Chinese Medicine Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Inventor 刘友平 陈鸿平 卢俊宇 王福 陈林 邱波 高真明 Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Pending Application number CN201510852080.8A Other languages Chinese ( zh)
SENNA LEAF PDF
Google Patents Preparation method of senna leaf processed productĭownload PDF Info Publication number CN105651905A CN105651905A CN201510852080.8A CN201510852080A CN105651905A CN 105651905 A CN105651905 A CN 105651905A CN 201510852080 A CN201510852080 A CN 201510852080A CN 105651905 A CN105651905 A CN 105651905A Authority CN China Prior art keywords preparation sennoside sennae sample senna Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents CN105651905A - Preparation method of senna leaf processed product CN105651905A - Preparation method of senna leaf processed product
0 kommentar(er)
